Cargando…
Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vector
Hypophosphatasia (HPP) is an inherited disease caused by genetic mutations in the gene encoding tissue-nonspecific alkaline phosphatase (TNALP). This results in defects in bone and tooth mineralization. We recently demonstrated that TNALP-deficient (Akp2(−/−)) mice, which mimic the phenotype of the...
Autores principales: | Nakamura-Takahashi, Aki, Miyake, Koichi, Watanabe, Atsushi, Hirai, Yukihiko, Iijima, Osamu, Miyake, Noriko, Adachi, Kumi, Nitahara-Kasahara, Yuko, Kinoshita, Hideaki, Noguchi, Taku, Abe, Shinichi, Narisawa, Sonoko, Millán, Jose Luis, Shimada, Takashi, Okada, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739158/ https://www.ncbi.nlm.nih.gov/pubmed/26904710 http://dx.doi.org/10.1038/mtm.2015.59 |
Ejemplares similares
-
Bone-Targeted Alkaline Phosphatase Treatment of Mandibular Bone and Teeth in Lethal Hypophosphatasia via an scAAV8 Vector
por: Ikeue, Ryo, et al.
Publicado: (2018) -
Treatment with bone maturation and average lifespan of HPP model mice by AAV8-mediated neonatal gene therapy via single muscle injection
por: Matsumoto, Tae, et al.
Publicado: (2021) -
Enzyme replacement in the CSF to treat metachromatic leukodystrophy in mouse model using single intracerebroventricular injection of self-complementary AAV1 vector
por: Hironaka, Kohei, et al.
Publicado: (2015) -
Prolonged Survival and Phenotypic Correction of Akp2(−/−) Hypophosphatasia Mice by Lentiviral Gene Therapy
por: Yamamoto, Seiko, et al.
Publicado: (2011) -
Targeted gene transfer into ependymal cells through intraventricular injection of AAV1 vector and long-term enzyme replacement via the CSF
por: Yamazaki, Yoshiyuki, et al.
Publicado: (2014)